A unique new flexible and stretchable device, worn against the skin and capable of producing electrical energy by transforming the compounds present in sweat, was recently developed and patented by CNRS researchers from l’Université Grenoble Alpes and UC San Diego (USA). This cell is already capable of continuously lighting an LED, opening new avenues for the development of wearable electronics powered by autonomous and environmentally friendly biodevices.
This research was published in Advanced Functional Materials on September 25, 2019.
The potential uses for wearable electronic devices continue to increase, especially for medical and athletic monitoring. Such devices require the development of a reliable and efficient energy source that can easily be integrated into the human body. Using “biofuels” present in human organic liquids has long been a promising avenue.
Scientists from the Département de chimie moléculaire (CNRS/Université Grenoble Alpes), who specialize in bioelectrochemistry, decided to collaborate with an American team from UC San Diego, who are experts in nanomachines, biosensors, and nanobioelectronics. Together they developed a flexible conductive material consisting of carbon nanotubes, crosslinked polymers, and enzymes joined by stretchable connectors that are directly printed onto the material through screen-printing1.
The biofuel cell, which follows deformations in the skin, produces electrical energy through the reduction of oxygen and the oxidation of the lactate present in perspiration.
Once applied to the arm, it uses a voltage booster to continuously power an LED. It is relatively simple and inexpensive to produce, with the primary cost being the production of the enzymes that transform the compounds found in sweat. The researchers are now seeking to amplify the voltage provided by the biofuel cell in order to power larger portable devices.
Learn more: Portable electronics: a stretchable and flexible biofuel cell that runs on sweat
The Latest on: Biofuel cell
[google_news title=”” keyword=”biofuel cell” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Biofuel cell
- Bio-Rad launches three StarBright Red Dyes and expands range of antibody markers conjugated to StarBright Violet Dyes to enhance immunology researchon May 1, 2024 at 9:19 am
StarBright Dyes are compatible with most experimental protocols and flow cytometers, including the Bio-Rad ZE5 Cell Analyzer, without the need for special buffers. Minimal lot-to-lot variation helps ...
- BIO survey to elucidate US biopharma's reliance on Chinese CDMOs amid decoupling threatson May 1, 2024 at 8:00 am
It’s no secret that U.S. biopharma companies rely on Chinese contractors to provide lab research and drug manufacturing services. | Facing a push for China-U.S. decoupling from Washington, the ...
- Barinthus Bio Names Experienced Physician, Leon Hooftman, M.D., as Chief Medical Officeron May 1, 2024 at 6:01 am
We are happy to welcome Dr. Hooftman to Barinthus Bio as our Chief Medical Officer. With his experience spearheading clinical studies from early development through late-stage trials, he is a valuable ...
- Tevogen Bio Announces Full Year 2023 Financial Results and Upcoming Operational Objectiveson May 1, 2024 at 5:18 am
For full year 2023, the operating expenses for Tevogen Bio Inc were $8.8 million. As previously announced, as of December 31, 2023, the conversion of promissory notes into common stock removed $94.9 ...
- Engineered living materials: Scientists 3D print with bio-ink made from tobacco cellson May 1, 2024 at 5:03 am
Also known as EPLMs, “engineered plant living materials” are a new frontier that marries synthetic biology and 3D printing, an invention that’s inspired many improvements to the mechanism itself as ...
- Bio-Techne beats third-quarter estimates on improving demand for biotech productson May 1, 2024 at 3:34 am
Bio-Techne on Wednesday beat third-quarter profit and revenue estimates, helped by better-than-expected demand for its cell and gene therapy products and testing and diagnostic devices.
- Caladan Bio raises $5m seed round to build next generation benchtop bioreactorson May 1, 2024 at 12:00 am
Caladan Bio—a startup making low-cost benchtop bioreactors to enhance data capture and increase throughput—has raised a $5m seed round ...
- Cell Therapy Manufacturing: Time to Move Faston April 30, 2024 at 9:54 am
The more quickly manufacturing and release obstructions can be cleared, the sooner lifesaving treatments can be administered.
- Gritstone bio Highlights the Durability and Potential Broad Utility of its Self-amplifying mRNA (samRNA) COVID-19 Vaccine at ESCMID Global 2024on April 30, 2024 at 6:00 am
IgG levels and neutralizing antibodies against variants of concern persisted for at least 12 months, consistent with previous findings ---- ...
- Mission Bio’s Tapestri Platform Unveils Insights into Targeted Therapy and Residual Disease Assessment for Multiple Myelomaon April 30, 2024 at 4:03 am
Mission Bio, a leader in single-cell multi-omics solutions for precision medicine, announced a new publication led by Hervé Avet-Loiseau, MD, PhD, revealing new insights into disease progression of ...
via Bing News